Highlights and Quick Summary
- Annual Accounts Receivable Turnover for 2021 was 20.6 (a 70.57% increase from previous year)
- Annual Accounts Receivable Turnover for 2021 was 12.08 (a 38.42% increase from previous year)
- Annual Accounts Receivable Turnover for 2020 was 8.73 (a 22.58% increase from previous year)
- Twelve month Accounts Receivable Turnover ending June 30, 2022 was 12.0 (a -28.68% decrease compared to previous quarter)
- Twelve month trailing Accounts Receivable Turnover increased by 1.53% year-over-year
Trailing Accounts Receivable Turnover for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| 12.0 | 16.83 | 11.14 | 11.82 |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Accounts Receivable Turnover of Biofrontera AG Sponsored ADR
Most recent Accounts Receivable Turnoverof BFAGY including historical data for past 10 years.Interactive Chart of Accounts Receivable Turnover of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Accounts Receivable Turnover for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 20.6 |
| 2020 | – | – | – | – | 8.73 |
| 2019 | – | – | – | – | 6.13 |
| 2018 | – | – | – | – | 6.06 |
| 2017 | – | – | – | – | 7.72 |
| 2016 | – | – | – | – | 3.73 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic